HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-MAR-09 3GQI TITLE CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX TITLE 2 WITH SUBSTRATES COMPND MOL_ID: 1; COMPND 2 MOLECULE: BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN; COMPND 5 SYNONYM: FGFR-1, BFGF-R, FMS-LIKE TYROSINE KINASE 2, C-FGR; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PHOSPHOLIPASE C-GAMMA-1; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: TANDEM SH2 DOMAINS; COMPND 13 SYNONYM: 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE COMPND 14 GAMMA-1, PHOSPHOINOSITIDE PHOSPHOLIPASE C, PLC-GAMMA-1, PLC-II, PLC- COMPND 15 148; COMPND 16 EC: 3.1.4.11; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFBR, FGFR1, FLG, FLT2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 10 ORGANISM_COMMON: RAT; SOURCE 11 ORGANISM_TAXID: 10116; SOURCE 12 GENE: PLCG1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHOSPHORYLATED KINASE, PY-RECOGNITION, TANDEM SH2 DOMAINS, ATP KEYWDS 2 ANALOG, ATP-BINDING, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE KEYWDS 3 BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC KEYWDS 4 HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, KINASE, KEYWDS 5 MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSFERASE, KEYWDS 6 TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, HYDROLASE, LIPID KEYWDS 7 DEGRADATION, SH2 DOMAIN, SH3 DOMAIN, TRANSDUCER, TRANSFERASE- KEYWDS 8 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.H.BAE,E.D.LEW,S.YUZAWA,F.TOME,I.LAX,J.SCHLESSINGER REVDAT 6 22-NOV-23 3GQI 1 REMARK REVDAT 5 06-SEP-23 3GQI 1 REMARK REVDAT 4 20-OCT-21 3GQI 1 REMARK SEQADV LINK REVDAT 3 01-NOV-17 3GQI 1 REMARK REVDAT 2 21-MAR-12 3GQI 1 JRNL VERSN REVDAT 1 18-AUG-09 3GQI 0 JRNL AUTH J.H.BAE,E.D.LEW,S.YUZAWA,F.TOME,I.LAX,J.SCHLESSINGER JRNL TITL THE SELECTIVITY OF RECEPTOR TYROSINE KINASE SIGNALING IS JRNL TITL 2 CONTROLLED BY A SECONDARY SH2 DOMAIN BINDING SITE. JRNL REF CELL(CAMBRIDGE,MASS.) V. 138 514 2009 JRNL REFN ISSN 0092-8674 JRNL PMID 19665973 JRNL DOI 10.1016/J.CELL.2009.05.028 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 26120 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.300 REMARK 3 FREE R VALUE TEST SET COUNT : 2608 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4222 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 77 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 80.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.92900 REMARK 3 B22 (A**2) : -16.78900 REMARK 3 B33 (A**2) : 8.86000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 16.04200 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.535 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 47.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ACP_DVT_PTR0.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ACP_DVT_PTR0.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3GQI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000052187. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27448 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.06700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 31.97 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1FGK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, TAURINE, PH 8.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 66.96750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.29800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 66.96750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.29800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 449 REMARK 465 GLY A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 HIS A 455 REMARK 465 HIS A 456 REMARK 465 MET A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 MET A 771 REMARK 465 PRO A 772 REMARK 465 LEU A 773 REMARK 465 ASP A 774 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 470 LYS A 540 CG CD CE NZ REMARK 470 ASN A 659 CG OD1 ND2 REMARK 470 ARG A 661 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 545 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 559 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 560 CG OD1 OD2 REMARK 470 PHE B 649 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 707 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 711 CD CE NZ REMARK 470 LYS B 713 CG CD CE NZ REMARK 470 ASN B 728 CG OD1 ND2 REMARK 470 LYS B 743 CG CD CE NZ REMARK 470 HIS B 744 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 749 CG CD CE NZ REMARK 470 LYS B 751 CD CE NZ REMARK 470 ARG B 753 CG CD NE CZ NH1 NH2 REMARK 470 PRO B 755 CG REMARK 470 ILE B 756 CG1 CG2 CD1 REMARK 470 GLU B 759 CG CD OE1 OE2 REMARK 470 GLU B 762 CG CD OE1 OE2 REMARK 470 LYS B 763 CG CD CE NZ REMARK 470 GLU B 768 CD OE1 OE2 REMARK 470 ASP B 770 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 466 105.39 -32.26 REMARK 500 ARG A 477 41.41 -97.09 REMARK 500 ASP A 519 30.54 -94.10 REMARK 500 ASP A 554 59.76 39.65 REMARK 500 SER A 565 -7.57 -57.74 REMARK 500 GLU A 582 -2.59 68.35 REMARK 500 HIS A 589 167.93 -43.73 REMARK 500 ASN A 590 103.08 -38.55 REMARK 500 ARG A 622 -2.68 72.48 REMARK 500 ASP A 623 46.65 -141.73 REMARK 500 ASP A 641 72.36 60.19 REMARK 500 PTR A 653 158.90 175.26 REMARK 500 THR A 658 -168.68 -75.27 REMARK 500 ASN A 724 67.10 62.16 REMARK 500 CYS A 725 117.33 -166.91 REMARK 500 THR A 726 165.30 -48.13 REMARK 500 LEU A 769 56.59 -98.55 REMARK 500 GLU B 548 -122.69 41.61 REMARK 500 LYS B 549 -123.96 71.94 REMARK 500 THR B 576 -2.15 -58.01 REMARK 500 ALA B 616 28.08 -71.44 REMARK 500 PRO B 643 -179.10 -55.67 REMARK 500 CYS B 646 -154.25 -129.25 REMARK 500 GLU B 648 -86.41 -56.50 REMARK 500 PHE B 649 -156.30 -148.24 REMARK 500 MET B 651 127.72 -179.37 REMARK 500 SER B 654 -93.63 -91.08 REMARK 500 PRO B 656 179.61 -52.38 REMARK 500 PRO B 686 68.98 -68.42 REMARK 500 GLU B 720 78.74 -113.96 REMARK 500 LEU B 726 78.36 -112.63 REMARK 500 TYR B 741 3.59 -67.72 REMARK 500 TYR B 747 107.85 -168.90 REMARK 500 ILE B 764 -53.86 -128.94 REMARK 500 THR B 766 -122.51 -107.36 REMARK 500 PRO B 769 -132.11 -76.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DVT A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACP A 775 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 776 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GQL RELATED DB: PDB DBREF 3GQI A 458 774 UNP P11362 FGFR1_HUMAN 458 774 DBREF 3GQI B 545 770 UNP P10686 PLCG1_RAT 545 770 SEQADV 3GQI MET A 449 UNP P11362 EXPRESSION TAG SEQADV 3GQI GLY A 450 UNP P11362 EXPRESSION TAG SEQADV 3GQI HIS A 451 UNP P11362 EXPRESSION TAG SEQADV 3GQI HIS A 452 UNP P11362 EXPRESSION TAG SEQADV 3GQI HIS A 453 UNP P11362 EXPRESSION TAG SEQADV 3GQI HIS A 454 UNP P11362 EXPRESSION TAG SEQADV 3GQI HIS A 455 UNP P11362 EXPRESSION TAG SEQADV 3GQI HIS A 456 UNP P11362 EXPRESSION TAG SEQADV 3GQI MET A 457 UNP P11362 EXPRESSION TAG SEQADV 3GQI ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 3GQI PHE A 583 UNP P11362 TYR 583 ENGINEERED MUTATION SEQADV 3GQI SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 3GQI PHE A 585 UNP P11362 TYR 585 ENGINEERED MUTATION SEQRES 1 A 326 MET GLY HIS HIS HIS HIS HIS HIS MET ALA GLY VAL SER SEQRES 2 A 326 GLU TYR GLU LEU PRO GLU ASP PRO ARG TRP GLU LEU PRO SEQRES 3 A 326 ARG ASP ARG LEU VAL LEU GLY LYS PRO LEU GLY GLU GLY SEQRES 4 A 326 ALA PHE GLY GLN VAL VAL LEU ALA GLU ALA ILE GLY LEU SEQRES 5 A 326 ASP LYS ASP LYS PRO ASN ARG VAL THR LYS VAL ALA VAL SEQRES 6 A 326 LYS MET LEU LYS SER ASP ALA THR GLU LYS ASP LEU SER SEQRES 7 A 326 ASP LEU ILE SER GLU MET GLU MET MET LYS MET ILE GLY SEQRES 8 A 326 LYS HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR SEQRES 9 A 326 GLN ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER SEQRES 10 A 326 LYS GLY ASN LEU ARG GLU TYR LEU GLN ALA ARG ARG PRO SEQRES 11 A 326 PRO GLY LEU GLU PHE SER PHE ASN PRO SER HIS ASN PRO SEQRES 12 A 326 GLU GLU GLN LEU SER SER LYS ASP LEU VAL SER CYS ALA SEQRES 13 A 326 TYR GLN VAL ALA ARG GLY MET GLU TYR LEU ALA SER LYS SEQRES 14 A 326 LYS CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU SEQRES 15 A 326 VAL THR GLU ASP ASN VAL MET LYS ILE ALA ASP PHE GLY SEQRES 16 A 326 LEU ALA ARG ASP ILE HIS HIS ILE ASP PTR PTR LYS LYS SEQRES 17 A 326 THR THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO SEQRES 18 A 326 GLU ALA LEU PHE ASP ARG ILE TYR THR HIS GLN SER ASP SEQRES 19 A 326 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE PHE THR SEQRES 20 A 326 LEU GLY GLY SER PRO TYR PRO GLY VAL PRO VAL GLU GLU SEQRES 21 A 326 LEU PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS SEQRES 22 A 326 PRO SER ASN CYS THR ASN GLU LEU TYR MET MET MET ARG SEQRES 23 A 326 ASP CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE SEQRES 24 A 326 LYS GLN LEU VAL GLU ASP LEU ASP ARG ILE VAL ALA LEU SEQRES 25 A 326 THR SER ASN GLN GLU PTR LEU ASP LEU SER MET PRO LEU SEQRES 26 A 326 ASP SEQRES 1 B 226 HIS SER SER GLU LYS TRP PHE HIS GLY LYS LEU GLY ALA SEQRES 2 B 226 GLY ARG ASP GLY ARG HIS ILE ALA GLU ARG LEU LEU THR SEQRES 3 B 226 GLU TYR CYS ILE GLU THR GLY ALA PRO ASP GLY SER PHE SEQRES 4 B 226 LEU VAL ARG GLU SER GLU THR PHE VAL GLY ASP TYR THR SEQRES 5 B 226 LEU SER PHE TRP ARG ASN GLY LYS VAL GLN HIS CYS ARG SEQRES 6 B 226 ILE HIS SER ARG GLN ASP ALA GLY THR PRO LYS PHE PHE SEQRES 7 B 226 LEU THR ASP ASN LEU VAL PHE ASP SER LEU TYR ASP LEU SEQRES 8 B 226 ILE THR HIS TYR GLN GLN VAL PRO LEU ARG CYS ASN GLU SEQRES 9 B 226 PHE GLU MET ARG LEU SER GLU PRO VAL PRO GLN THR ASN SEQRES 10 B 226 ALA HIS GLU SER LYS GLU TRP TYR HIS ALA SER LEU THR SEQRES 11 B 226 ARG ALA GLN ALA GLU HIS MET LEU MET ARG VAL PRO ARG SEQRES 12 B 226 ASP GLY ALA PHE LEU VAL ARG LYS ARG ASN GLU PRO ASN SEQRES 13 B 226 SER TYR ALA ILE SER PHE ARG ALA GLU GLY LYS ILE LYS SEQRES 14 B 226 HIS CYS ARG VAL GLN GLN GLU GLY GLN THR VAL MET LEU SEQRES 15 B 226 GLY ASN SER GLU PHE ASP SER LEU VAL ASP LEU ILE SER SEQRES 16 B 226 TYR TYR GLU LYS HIS PRO LEU TYR ARG LYS MET LYS LEU SEQRES 17 B 226 ARG TYR PRO ILE ASN GLU GLU ALA LEU GLU LYS ILE GLY SEQRES 18 B 226 THR ALA GLU PRO ASP MODRES 3GQI PTR A 653 TYR O-PHOSPHOTYROSINE MODRES 3GQI PTR A 654 TYR O-PHOSPHOTYROSINE MODRES 3GQI PTR A 766 TYR O-PHOSPHOTYROSINE HET PTR A 653 16 HET PTR A 654 16 HET PTR A 766 16 HET DVT A 1 38 HET ACP A 775 31 HET MG A 776 1 HETNAM PTR O-PHOSPHOTYROSINE HETNAM DVT DECAVANADATE HETNAM ACP PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER HETNAM MG MAGNESIUM ION HETSYN PTR PHOSPHONOTYROSINE HETSYN ACP ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE FORMUL 1 PTR 3(C9 H12 N O6 P) FORMUL 3 DVT O28 V10 6- FORMUL 4 ACP C11 H18 N5 O12 P3 FORMUL 5 MG MG 2+ FORMUL 6 HOH *77(H2 O) HELIX 1 1 THR A 521 GLY A 539 1 19 HELIX 2 2 ASN A 568 ALA A 575 1 8 HELIX 3 3 SER A 596 LYS A 617 1 22 HELIX 4 4 ALA A 625 ARG A 627 5 3 HELIX 5 5 PRO A 663 MET A 667 5 5 HELIX 6 6 ALA A 668 ASP A 674 1 7 HELIX 7 7 THR A 678 THR A 695 1 18 HELIX 8 8 PRO A 705 GLU A 715 1 11 HELIX 9 9 THR A 726 TRP A 737 1 12 HELIX 10 10 VAL A 740 ARG A 744 5 5 HELIX 11 11 THR A 746 SER A 762 1 17 HELIX 12 12 LEU B 555 ARG B 559 5 5 HELIX 13 13 ASP B 560 GLY B 577 1 18 HELIX 14 14 SER B 631 VAL B 642 1 12 HELIX 15 15 ASN B 661 LYS B 666 5 6 HELIX 16 16 THR B 674 ARG B 684 1 11 HELIX 17 17 SER B 733 GLU B 742 1 10 HELIX 18 18 ASN B 757 GLU B 762 1 6 SHEET 1 A 5 LEU A 478 GLU A 486 0 SHEET 2 A 5 GLN A 491 ILE A 498 -1 O GLU A 496 N VAL A 479 SHEET 3 A 5 VAL A 508 MET A 515 -1 O MET A 515 N GLN A 491 SHEET 4 A 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 B 2 CYS A 619 ILE A 620 0 SHEET 2 B 2 ARG A 646 ASP A 647 -1 O ARG A 646 N ILE A 620 SHEET 1 C 2 VAL A 629 VAL A 631 0 SHEET 2 C 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 D 2 PTR A 654 LYS A 655 0 SHEET 2 D 2 ILE A 676 TYR A 677 -1 O TYR A 677 N PTR A 654 SHEET 1 E 6 PHE B 551 GLY B 553 0 SHEET 2 E 6 PHE B 583 GLU B 587 1 O VAL B 585 N HIS B 552 SHEET 3 E 6 TYR B 595 TRP B 600 -1 O THR B 596 N ARG B 586 SHEET 4 E 6 VAL B 605 ARG B 613 -1 O CYS B 608 N LEU B 597 SHEET 5 E 6 LYS B 620 THR B 624 -1 O PHE B 622 N HIS B 611 SHEET 6 E 6 LEU B 627 PHE B 629 -1 O PHE B 629 N PHE B 621 SHEET 1 F 6 TYR B 669 HIS B 670 0 SHEET 2 F 6 ALA B 690 LYS B 695 1 O VAL B 693 N HIS B 670 SHEET 3 F 6 SER B 701 ALA B 708 -1 O ALA B 703 N ARG B 694 SHEET 4 F 6 LYS B 711 GLU B 720 -1 O CYS B 715 N ILE B 704 SHEET 5 F 6 THR B 723 LEU B 726 -1 O THR B 723 N GLU B 720 SHEET 6 F 6 SER B 729 PHE B 731 -1 O PHE B 731 N VAL B 724 SHEET 1 G 3 TYR B 669 HIS B 670 0 SHEET 2 G 3 ALA B 690 LYS B 695 1 O VAL B 693 N HIS B 670 SHEET 3 G 3 TYR B 754 PRO B 755 1 O TYR B 754 N PHE B 691 LINK C ASP A 652 N PTR A 653 1555 1555 1.34 LINK C PTR A 653 N PTR A 654 1555 1555 1.32 LINK C PTR A 654 N LYS A 655 1555 1555 1.34 LINK C GLU A 765 N PTR A 766 1555 1555 1.32 LINK C PTR A 766 N LEU A 767 1555 1555 1.33 CISPEP 1 ASN A 586 PRO A 587 0 -0.23 SITE 1 AC1 13 ASP A 503 LYS A 504 PRO A 505 ASN A 506 SITE 2 AC1 13 ARG A 507 HOH B 34 LEU B 673 THR B 674 SITE 3 AC1 13 ARG B 675 ARG B 694 ARG B 696 ASN B 697 SITE 4 AC1 13 GLU B 698 SITE 1 AC2 17 LEU A 484 GLY A 485 GLY A 487 ALA A 488 SITE 2 AC2 17 PHE A 489 GLY A 490 VAL A 492 ALA A 512 SITE 3 AC2 17 LYS A 514 GLU A 562 ALA A 564 ASN A 568 SITE 4 AC2 17 ARG A 627 ASN A 628 LEU A 630 ASP A 641 SITE 5 AC2 17 MG A 776 SITE 1 AC3 3 ASN A 628 ASP A 641 ACP A 775 CRYST1 133.935 64.596 94.209 90.00 96.50 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007466 0.000000 0.000851 0.00000 SCALE2 0.000000 0.015481 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010683 0.00000